Treloar C - Search Results

1

Incidence of hepatitis C virus infection in the prison setting: The SToP-C study.

Hajarizadeh B, Carson JM, Byrne M, Grebely J, Cunningham E, Amin J, Vickerman P, Martin NK, Treloar C, Martinello M, Lloyd AR, Dore GJ; SToP-C study group. Hajarizadeh B, et al. Among authors: treloar c. J Viral Hepat. 2024 Jan;31(1):21-34. doi: 10.1111/jvh.13895. Epub 2023 Nov 7. J Viral Hepat. 2024. PMID: 37936544 Free PMC article.

2

Treloar CJ, Hopwood MN, Loveday SK. Treloar CJ, et al. Med J Aust. 2002 Sep 2;177(5):233-4. doi: 10.5694/j.1326-5377.2002.tb04753.x. Med J Aust. 2002. PMID: 12197815 No abstract available.

3

Knowledge and attitudes about treatment for hepatitis C virus infection and barriers to treatment among current injection drug users in Australia.

Doab A, Treloar C, Dore GJ. Doab A, et al. Among authors: treloar c. Clin Infect Dis. 2005 Apr 15;40 Suppl 5:S313-20. doi: 10.1086/427446. Clin Infect Dis. 2005. PMID: 15768340

4

Uptake and delivery of hepatitis C treatment in opiate substitution treatment: perceptions of clients and health professionals.

Treloar C, Newland J, Rance J, Hopwood M. Treloar C, et al. J Viral Hepat. 2010 Dec;17(12):839-44. doi: 10.1111/j.1365-2893.2009.01250.x. J Viral Hepat. 2010. PMID: 20070504

5

Is point of access to needles and syringes related to needle sharing? Comparing data collected from pharmacies and needle and syringe programs in south-east Sydney.

Bryant J, Topp L, Hopwood M, Iversen J, Treloar C, Maher L. Bryant J, et al. Among authors: treloar c. Drug Alcohol Rev. 2010 Jul;29(4):364-70. doi: 10.1111/j.1465-3362.2009.00154.x. Drug Alcohol Rev. 2010. PMID: 20636651

6

Factors associated with specialist assessment and treatment for hepatitis C virus infection in New South Wales, Australia.

Grebely J, Bryant J, Hull P, Hopwood M, Lavis Y, Dore GJ, Treloar C. Grebely J, et al. Among authors: treloar c. J Viral Hepat. 2011 Apr;18(4):e104-16. doi: 10.1111/j.1365-2893.2010.01370.x. Epub 2010 Sep 14. J Viral Hepat. 2011. PMID: 20840350

7

Factors associated with hepatitis C knowledge among a sample of treatment naive people who inject drugs.

Treloar C, Hull P, Bryant J, Hopwood M, Grebely J, Lavis Y. Treloar C, et al. Drug Alcohol Depend. 2011 Jul 1;116(1-3):52-6. doi: 10.1016/j.drugalcdep.2010.11.018. Epub 2010 Dec 30. Drug Alcohol Depend. 2011. PMID: 21194852

8

Knowledge and barriers associated with assessment and treatment for hepatitis C virus infection among people who inject drugs.

Treloar C, Hull P, Dore GJ, Grebely J. Treloar C, et al. Drug Alcohol Rev. 2012 Nov;31(7):918-24. doi: 10.1111/j.1465-3362.2012.00468.x. Epub 2012 May 21. Drug Alcohol Rev. 2012. PMID: 22612899

9

Assessment and treatment of hepatitis C virus infection among people who inject drugs in the opioid substitution setting: ETHOS study.

Alavi M, Grebely J, Micallef M, Dunlop AJ, Balcomb AC, Day CA, Treloar C, Bath N, Haber PS, Dore GJ; Enhancing Treatment for Hepatitis C in Opioid Substitution Settings (ETHOS) Study Group. Alavi M, et al. Among authors: treloar c. Clin Infect Dis. 2013 Aug;57 Suppl 2:S62-9. doi: 10.1093/cid/cit305. Clin Infect Dis. 2013. PMID: 23884068

10

Client and staff experiences of a co-located service for hepatitis C care in opioid substitution treatment settings in New South Wales, Australia.

Treloar C, Rance J, Grebely J, Dore GJ. Treloar C, et al. Drug Alcohol Depend. 2013 Dec 1;133(2):529-34. doi: 10.1016/j.drugalcdep.2013.07.023. Epub 2013 Aug 2. Drug Alcohol Depend. 2013. PMID: 23932843

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

282 results

Search Page